The present proposal is submitted in response to research grants announcement in the area of epidermolysis bullosa (EB) and basement membrane zone biology. The proposed studies are designed to test the hypothesis that mutations in the genes that code for the matrix structural macromolecules of the basement membrane zone in skin cause one or more forms of EB. The proposal entails concentrated, multidisciplinary studies performed by experts representing different scientific disciplines and all now participating in collaborative research within the Jefferson Institute of Molecular Medicine. The five component projects are highly interdependent. Project 1, """"""""Clinical and Ultrastructural Studies,"""""""" will provide the essential patient material and critical clinical information on the patients, the morphological changes in the skin, and the distribution of specific antigens that will guide work on the other projects. The data generated in Project 2, """"""""Use of Restriction Fragment Length Polymorphism for Linkage Studies,"""""""" are vital to ruling in or ruling out specific genes and alleles as candidates for mutations that will be explored in greater detail in Projects 3 and 4. Project 3, """"""""Genetic Defects in the Biosynthesis of Basement Membrane Zone Macromolecules,"""""""" will provide information on the gene-protein systems that may be at fault in various forms of EB. The work on this project, primarily concentrating on elucidation of structural alterations in basement membrane zone macromolecules at the protein and mRNA level, will thus provide necessary information about mutations that will be explored in detail on Project 4. Project 4, """"""""Mutations in Genes Expressed in Skin,"""""""" will use the techniques of molecular biology to define precisely the gene mutations. Such information will then provide a basis for definitive classification of the variants of EB identified in Projects 1, 2 and 3. Project 5, """"""""New Clones and Structures for Genes Expressed in Skin,"""""""" will provide additional gene probes and information about the normal gene structures that are essential for studies in Projects 2, 3, and 4. These multidisciplinary studies are expected to provide precise information on the underlying molecular defects in various forms of EB. Such information is of critical importance in developing definitive classifications for this disease, for development of prenatal diagnostic tests, and to provide a basis for developing therapeutic approaches for this disease. In addition, the projects will generate materials, technologies and information that can serve as a permanent resource for future studies on EB and other heritable diseases affecting skin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Program Projects (P01)
Project #
5P01AR038923-02
Application #
3092392
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1987-08-15
Project End
1992-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Mahoney, My G; Sadowski, Sara; Brennan, Donna et al. (2010) Compound heterozygous desmoplakin mutations result in a phenotype with a combination of myocardial, skin, hair, and enamel abnormalities. J Invest Dermatol 130:968-78
Chung, Hye Jin; Uitto, Jouni (2010) Epidermolysis bullosa with pyloric atresia. Dermatol Clin 28:43-54
Chung, Hye Jin; Uitto, Jouni (2010) Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa. Dermatol Clin 28:93-105
Remington, Jennifer; Wang, Xinyi; Hou, Yingpin et al. (2009) Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther 17:26-33
Uitto, Jouni (2009) Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies*. Acta Derm Venereol 89:228-35
Lugassy, Jennie; McGrath, John A; Itin, Peter et al. (2008) KRT14 haploinsufficiency results in increased susceptibility of keratinocytes to TNF-alpha-induced apoptosis and causes Naegeli-Franceschetti-Jadassohn syndrome. J Invest Dermatol 128:1517-24
Igoucheva, Olga; Kelly, Aislinn; Uitto, Jouni et al. (2008) Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro. J Invest Dermatol 128:1476-86
Nakajima, Koji; Tamai, Katsuto; Yamazaki, Takehiko et al. (2008) Identification of Skn-1n, a splice variant induced by high calcium concentration and specifically expressed in normal human keratinocytes. J Invest Dermatol 128:1336-9
Varki, Roslyn; Sadowski, Sara; Uitto, Jouni et al. (2007) Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet 44:181-92
Nyquist, Gurston G; Mumm, Christina; Grau, Renee et al. (2007) Malignant proliferating pilar tumors arising in KID syndrome: a report of two patients. Am J Med Genet A 143:734-41

Showing the most recent 10 out of 333 publications